Rabin Medical Center
Petah Tikva, 49100, Israel
NCT Number: NCT04399408
Mobile medical devices for self-patient-use, are a rapidly evolving component of telehealth. Study examines the feasibility of using the INSTINCT® device, a portable self-use ultrasound system attached to a commercial smartphone in remote pregnancy assessment. Study aims to evaluate its safety, efficacy and usability.
Looking for future studies?
Notify Me18 year and older
Female
Interventional
Not applicable
Petah Tikva, 49100, Israel
Study includes women carrying a singleton fetus at 14 to 40 gestational weeks. Women with multiple gestations, non-viable fetus at recruitment and those with a major fetal anatomical malformation or genetic syndrome are excluded. Each participant receives the device for a self-use period of 7-14 days, instructed to preform 1-3 scans a day. Each participant completes a self-assessment questionnaire which aims to evaluate satisfactory and usability (user experience and satisfaction). Each scan will be evaluated for the possibility to properly view fetal heart activity, amniotic fluid volume, fetal tone, fetal body and breathing movements.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Participants are instructed to preform 1-3 short (3 minuets) ultrasound scans a day according to pre-defined steps.
Time frame: Through study completion until all subject gave birth, an average of 1 year
The device will be deemed safe if all SAE will be classified as not device related
Time frame: Through study completion, an average of 1 year
User experience will be defined positive if the mean value of all answers to user satisfaction related questions in the CRF is better or equal 3.5 out of 5. Questions will be graded by a visual analog scale with scores of 1 to 5 (1=very poor, 5=very high)
Time frame: Through study completion, an average of 1 year
Usability will be defined positive if the mean value of all answers to usability related questions in the CRF is better or equal 3.5 out of 5. Questions will be graded by a visual analog scale with scores of 1 to 5 (1=very poor, 5=very high)
Time frame: Through study completion, an average of 1 year
Medical data recorded by the device will be defined useful if:
At least 70% of 3 out of 5 tested parameters (Fetal Heartbeat, Movements, Tone, Breathing and Amniotic fluids) were classified by professional evaluator as "could be estimated".
In more than 90% of scans, professional evaluator will be able to define Fetal Viability (identification of at least one of the following parameters: Fetal Heartbeat, Movements, Tone and Breathing)
PulseNmore
Industry
Mobile, Self-Operated, Home Ultrasound in Pregnancy - Safety, Efficacy and Usability
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04441866
Ultrasonography, Prenatal
Brescia, Italy
View Trial DetailsNCT02456753
Ultrasonography, Prenatal
Lille, Hauts-de-France, France
View Trial Details